Tags : Treating

M&A

STADA Expands its Specialty Footprint with the Acquisition of Lobsor

Shots:   STADA acquires Lobsar and its innovative therapy to foster its footprints in specialty pharmaceuticals. The acquisition complements STADA’s portfolio and expertise in the treatment of late-stage Parkinson’s disease With the acquisition, STADA gain rights to a triple fixed combination (levodopa/carbidopa/ entacapone) delivered via modern pump technology, already launched in Nordic countries Levodopa, carbidopa and […]Read More

Pharma

IMIDomics Collaborates with Gossamer Bio to Develop Therapies for Treating

Shots: The companies collaborates on multiple projects, being the first for inflammatory bowel disease(IBD) to develop and discover therapies for treating Immune-Mediated Inflammatory Diseases (IMIDs) The focus of the collaboration will allow Gossamer’s immunology research and development team to utilize IMIDomics’ unique clinical and molecular patient database for product discovery and development strategy IMIDomics’ platform […]Read More